|
answer text |
<p>Molecular radiotherapy is currently commissioned alongside brachytherapy via a
national service specification. There are currently 38 trusts in England that are
commissioned to deliver these services however, given the spectrum of treatments available
under this service specification, there is some variation in what each provider offers.</p><p>For
this reason, NHS England is developing a standalone molecular radiotherapy service
specification. This will clarify the service model and review demand and access arrangements.
The service specification will also take into account any future developments in treatment
technologies and recommendations made by the National Institute for Health and Care
Excellence.</p>
|
|